Isolation and infusion of donor CD34+ bone marrow cells in cadaver kidney transplantation

Nephrology Dialysis Transplantation

Volumn 13, Issue 1, 1998, Pages 34-36

  De Pauw, Luc ^a   Abramowicz, Daniel ^a   Donckier, Vincent ^a   Kornreich, Anne ^a   Destrée, Martine ^b   Demoor, François ^a   Andrien, Marc ^a   Lambermont, Micheline ^a   Goldman, Michel ^a  

^a ERASME HOSPITAL   (Belgium)

^b Cellpro Europe ^*  (Belgium)

Author keywords

Bone marrow; Kidney transplantation; Stem cell; Tolerance

Indexed keywords

CD34 ANTIGEN; CYCLOSPORIN A; OKT 3; PREDNISOLONE;

ADULT; ARTICLE; BONE MARROW CELL; CADAVER KIDNEY; CELL ISOLATION; CHIMERA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; GRAFT REJECTION; HLA MATCHING; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STEM CELL; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

ADULT; ANTIGENS, CD34; CADAVER; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; KIDNEY TRANSPLANTATION; MIDDLE AGED;

EID: 0031962639     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/13.1.34     Document Type: Article

References (17)

1. Monaco AP, Wood ML, Gray JG et al. Studies on heterologous anti-lymphocyte serum in mice. II. Effect on the immune response. J Immunol 1966; 96: 229-238
2. Thomas JM, Carver M, Cunningham P et al. Promotion of incompatible allograft acceptance in rhesus monkeys given posttransplant antithymocyte globulin and donor bone marrow: I. In vivo parameters and immunohistologic evidence suggesting microchimerism. Transplantation 1987; 43: 332-338
3. Thomas JM, Verbanac KM, Smith JP et al. The facilitating effect of one-DR antigen sharing in renal allograft tolerance induced by donor bone marrow in rhesus monkeys. Transplantation 1995; 59: 245-255
4. Barber WH, Mankin JA, Laskow DA et al. Long-term results of a controlled prospective study with transfusion of donorspecific bone marrow in 57 cadaveric renal allograft recipients. Transplantation 1991; 51: 70-75
5. Fontes P, Rao AS, Demetris AJ et al. Augmentation with donor bone marrow of donor leukocyte migration for kidney, liver, heart, and pancreas islet transplantation. Lancet 1994; 344: 151-155
6. Ricordi C, Karatzas T, Nery J et al. High-dose donor bone marrow infusions to enhance allograft survival. The effect of timing. Transplantation 1997; 63: 7-11
7. Thomas JM, Carver FM, Cunningham PRG, Olson LC, Thomas FT. Kidney allograft tolerance in primates without chronic immunosuppression: the role of veto cells Transplantation 1991; 51: 198-207
8. Verbanac K.M, Carver FM, Haisch CE, Thomas JM. A role for transforming growth factor-beta in the veto mechanism in transplantation tolerance. Transplantation 1994; 57: 893-900
9. + hematopoietic cells. Blood 1996; 88: 2619-2675
10. Garcia-Morales R, Esquenazi V, Zucker K et al. An assessment of the effects of cadaver donor bone marrow on kidney allograft recipient blood cell chimerism by a novel technique combining PCR and flow cytometry. Transplantation 1996; 62: 1149-1160
11. Sharp TG, Sachs DH, Mathews JG. Harvest of human bone marrow directly from bone. J Immunol Methods 1984; 69: 187-195
12. Goldman M, Abramowicz D, De Pauw L et al. OKT3-induced cytokine release syndrome: attenuation by high doses of methylprednisolone. Lancet 1989; 2: 802-803
13. Bein G, Gläser R, Kirchner H. Rapid HLA-DRB1 genotyping by nested PCR amplification. Tissue Antigens 1992; 39: 68-73
14. Inamdar A, Sintasath DM, Husted L et al. Typing the HLA-B locus by a nested primer approach and oligonucleotide hybridization. Tissue Antigens 1996; 47: 519-529
15. Reisner Y, Martelli MF. Bone marrow transplantation across HLA barriers by increasing the number of transplanted cells, Immunol Today 1995; 9: 437-440
16. Wood ML, Monaco AP, Gozzo JJ, Liegois A. Use of homozygous allogeneic bone marrow for induction of tolerance with antilymphocyte serum: dose and timing. Transplant Proc 1971; 3: 676-679
17. Brugger W, Heimfeld S, Berenson RJ, Mertelsmann R, Kanz L. Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo. N Engl J Med 1995; 333: 283-287